Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

SONUS Pharmaceuticals

SONUS Pharmaceuticals News Editors

News Widget

Display the SONUS Pharmaceuticals news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

SONUS Pharmaceuticals News

News on SONUS Pharmaceuticals (Ticker: OGXI) continually updated from thousands of sources around the net.

Saturday May 5 | AmericanBankingNews.com

OncoGenex Pharmaceuticals PT Cut to $18.00 at Bloom Burton & Co.

The firm currently has a "buy" rating on the stock. The analysts wrote, "Our multiple is in line with other companies at a similar stage of development, but we apply a 33% instead of 30% discount rate to account for the higher risk associated with developing a new product for cancer.

Comment?

Related Topix: Biotech, Medicine, OncoGenex Pharmaceuticals, Healthcare Industry

Wed Apr 25, 2012

Freshnews

OncoGenex to Webcast Discussion of First Quarter 2012 Financial Results on Thursday, May 3, 2012

BOTHELL, WA and VANCOUVER, April 25, 2012 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc.

Comment?

Related Topix: Bothell, WA, Biotech, Medicine, OncoGenex Pharmaceuticals, Healthcare Industry, Oncology, Teva Pharmaceutical Industries, Prostate Cancer, Health

Tue Apr 03, 2012

Stockopedia

Trial changes and cash

Apr 03rd 2012 - Edison Investment Research today published a report on OncoGenex Pharmaceuticals entitled "Trial Changes And Cash". In summary, the report says: OncoGenex has made important changes to the clinical programme for its lead product custirsen with its partner Teva and raised $53.8m. The changes to the pivotal Phase III SYNERGY trial ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, OncoGenex Pharmaceuticals, Prostate Cancer, Health

Tue Mar 27, 2012

Freshnews

OncoGenex Pharmaceuticals to Present at Two Upcoming Investor Conferences

BOTHELL, WA and VANCOUVER, BC, March 27, 2012 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc.

Comment?

Related Topix: Biotech, Medicine, OncoGenex Pharmaceuticals, Healthcare Industry, Bothell, WA, Oncology, Teva Pharmaceutical Industries, Prostate Cancer, Health

AmericanBankingNews.com

Leerink Analysts Begin Coverage on OncoGenex Pharmaceuticals

Research analysts at Leerink assumed coverage on shares of OncoGenex Pharmaceuticals in a report issued on Tuesday.

Comment?

Related Topix: Biotech, Medicine, OncoGenex Pharmaceuticals, Healthcare Industry

Los Angeles Jobs

Also on Topix